Factsheet – EU delivering on rare diseases for patients and families

1:1
Overview of how the European Union supports patients with rare diseases through coordinated policy, research, and healthcare collaboration.

This factsheet presents the European Union’s actions to improve the lives of people living with rare diseases and their families. It outlines key areas of work, including strengthening European Reference Networks (ERNs), supporting research and innovation, improving access to diagnosis and treatment, and enhancing cooperation across Member States.

The document also highlights recent achievements and ongoing initiatives aimed at improving healthcare systems, data sharing, and patient support across Europe.

Year of publication

2026

Source

European Commission – Directorate-General for Health and Food Safety

Author

Directorate-General for Health and Food Safety (European Commission)

You might also be interested in

Call text draft setting out rules, eligibility and staged application process for the ERDERA Clinical Trial Call 2026.
June 7 - June 10
The Open Academy x ERDERA accompanies patient advocates by offering rare-disease specific comprehensive training programmes that empower advocates with the knowledge, skills and confidence they need to engage with different stakeholders as equal partners.
ERDERA’s ethics and regulatory experts are launching a dedicated webinar series to help the rare disease research community navigate two fast-moving areas of biomedical research: Advanced Therapy Medicinal Products (ATMPs) and Artificial Intelligence.
July 24 @ 3:00 pm - 4:00 pm
This webinar will present a theoretical framework for situating ethics across research activities. The framework will then be brought to life through a relevant case study discussion, giving participants a concrete reference point for the episodes ahead.